MLTO.PK : Revenues Increase 75% Over July,Going to be a hot ,Check news

[wrangler]

Press Release Source: MEDirect Latino Inc.


MEDirect Latino Inc. Achieves Record August Operational Results
Monday September 12, 5:46 pm ET 
Revenues Increase 75% Over July, With New Client Shipments Increasing 110%


PLANTATION, Fla.--(BUSINESS WIRE)--Sept. 12, 2005--MEDirect Latino Inc. (OTC:MLTO - News) - http://www.medirectlatino.org -, the leading provider of direct-to-consumer Medicare reimbursed healthcare products to the Hispanic community, today announced record results for August 2005 in gross billings, new patient shipments, call volume and average opening orders. MEDirect Latino reports gross billings of $145,984 during the month, a 75% increase over July billings of $83,658. The Company realized gross product profit margins of 74% during the period, compared to 68% in July. During the month, the Company's media campaign produced patient intake call volume of 1,956 calls, an increase of 34% over July. Total patient orders for August numbered 1,150, which included 638 new patient shipments, and an additional 512 patients approved, but pending shipment for regulatory processing. MEDirect Latino expects to monetize its approved/on-hold patients in September, which is typical to the industry model. The Company's closing ratio during August was 58% of the total response rate from the media campaign. New patient shipments in August increased 110% over new patient shipments in July.

[wrangler]

Hope someone noticed my post.MLTO.PK is up 17.95% since my last post.From2.60 to 3.00

[wrangler]

 Press Release Source: MEDirect Latino Inc.


Wall Street Resources Releases Updated Analytical Profile on MEDirect Latino, Revises 12-Month Target Value of $11.25
Thursday September 22, 9:18 am ET
Price Upgrade Due to the Company Exceeding Performance Criteria in Initial Report


PLANTATION, Fla., Sept. 22, 2005 (PRIMEZONE) -- MEDirect Latino Inc. (Other OTC:MLTO.PK - News) http://www.medirectlatino.org today announced the release of an updated analytical profile on the Company, by respected micro-cap valuation expert, Mr. Gerald Kieft, founder and President of Wall Street Resources, Inc, which has upgraded the short term price target of MLTO to $11.25 per share. This report is an update of the original report issued on May 16, 2005, where Wall Street Resources issued a 12-month target value of $8.40 per share. The increase in valuation is due to the recent reported results of the Company, its increasing sales and shipping volume and diversification of its products and services, which has resulted in a higher initial order value per new client.
The free report is available at: http://www.wallstreetresources.net/pdf/fc/MLTO2.pdf

[wrangler]

Press Release Source: MEDirect Latino Inc.


The Research Works, Inc. Initiates Coverage of MEDirect Latino Inc. with Initial Price Target of $14 Per Share
Tuesday October 4, 9:00 am ET
Report Details Substantial Growth Prospects for Company as First Mover in Hispanic Medicare Eligible Market


PLANTATION, Fla., Oct. 4, 2005 (PRIMEZONE) -- MEDirect Latino Inc. (Other OTC:MLTO.PK - News) (http://www.medirectlatino.org), today announced that The Research Works, Inc. has released an analyst research report covering the company with an initial price target of $14.00. The report is now available for review at: http://www.stocksontheweb.com/mlto.pdf
ADVERTISEMENT


``The Research Works was chosen to evaluate MEDirect Latino due to the reputation of the company's president, Mr. William J. Ritger, and the in-depth knowledge he has of the health care sector. Few analysts have the historical knowledge and deep insight in the microcap space as does Mr. Ritger. During his career, Bill has analyzed hundreds of microcap and small cap companies and has proven himself to be extraordinarily knowledgeable in this underserved, but opportunity-rich market,'' stated Mr. Raymond J. Talarico, CEO and co-chairman of the board of MEDirect Latino.

The Research Works is an equity research boutique founded in 1992 that focuses on small cap, microcap, and penny stocks. The Research Works' stated objective is to discover undervalued small companies and help them achieve fair value for their stocks by producing high-quality, paid research reports that are grounded in fundamental analysis and employ state-of-the-art equity valuation models. The Research Works targets a far-reaching network of sophisticated, self-directed investors and distributes its research through a strong Internet presence and a large direct distribution list.

``We believe that the Research Works report and the recent updated analytical valuation study by Wall Street Research, clearly shows that our stock is grossly undervalued. As we continue to educate the market about the MEDirect Latino business model, coupled with the upcoming announcement of our September operating results on October 10th, we continue to validate our projections and earning estimates. MEDirect Latino's monthly revenue increases are bringing additional attention to the Company, as the only national provider focused on the Medicare eligible Hispanic marketplace,'' added Mr. Talarico.

:

[wrangler]

Source: MEDirect Latino Inc.

MEDirect Latino Inc. Achieves Record September Operating Results
Revenues Increase 109 Percent Over August, While New Client Shipments Increase 104 Percent
PLANTATION, Fla., Oct. 10, 2005 (PRIMEZONE) -- MEDirect Latino Inc. (Pink Sheets:MLTO) (www.medirectlatino.org), the first national provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community, today announced record operating results for September, 2005 in gross billings, new patient shipments, call volume and average opening orders. MEDirect Latino reports gross billings of $304,621 during the month, a 109% increase over August billings of $145,984, while maintaining gross product profit margins of 74% during the period. During the month, the Company's media campaign produced qualified patient intake call volume of 3,772 calls, an increase of 93% over August. Total patient orders for September numbered 3,108, which included 1,304 new patient shipments, and an additional 1,804 patients approved, but pending shipment for regulatory processing. MEDirect Latino expects to monetize its approved/on-hold patients in October, which is typical for the industry model. The Company's closing ratio during August was 82% of the total qualified responses received from the media campaign. New patient shipments in September increased 104% over new patient shipments in August.


Mr. Raymond Talarico, Co-Chairman and CEO of MEDirect Latino, in discussing the Company's September results stated: "Our revenue increases prove the viability of the Hispanic Medicare market for our products and services and the fact that our media campaign, with increasing effectiveness, is reaching our targeted customer. Our proprietary research and marketing program, which was developed and is being implemented by Company COO Mr. Charles Hansen, is one of the cornerstones of the success of our business, and continues to prove itself in Puerto Rico while our domestic campaign, which launched nationally on Telemundo September 20th, has been overwhelmingly successful. As we continue to outperform projections, the Company has stepped up efforts to hire, train and educate new employees on the methods MEDirect employs in the sales, care and service we provide our customers. MEDirect, in the Hispanic community, is quickly becoming recognized as a provider of healthcare products and services that cares about our Latin customers and their families. This is the vision the Company was founded upon, and this vision has become intertwined with our corporate culture."

Senior management will attend Medtrade Conference & Exposition, October 17-20, 2005, at the Georgia World Congress Center, to finalize agreements to distribute additional products to the Company's growing Hispanic Medicare customer database. The Company's product extension goals focus on products which complement its existing line of branded and co-branded diabetic diagnostic testing supplies in the Medicare reimbursable regime, which offer natural extensions and enhance the quality of life of its customers. In addition, the Company will complete discussions with international manufacturers and distributors to initiate commercial distribution of its branded line of culturally specific diabetic care products, into Mexico, Central, and South America.

ANALYTICAL REPORTS

Additional Company information may be obtained by reviewing a detailed research report published by noted micro-cap analyst, Mr. William Ritger, President of The Research Works, Inc. covering MEDirect Latino. The report is now available for review at: http://www.stocksontheweb.com/mlto.pdf.

[wrangler]

Wall Street News Alert's  for

Thursday, November 10, 2005.

BREAKING NEWS ALERT: MEDIRECT LATINO INC. ACHIEVES RECORD OCTOBER REVENUE RESULTS DESPITE INTERRUPTIONS CAUSED BY HURRICANE WILMA. Revenues Increase 37% Over September, New Client Shipments Increase 19%.

[cmzabak]

come join the yahoo group for MLTO...http://finance.groups.yahoo.com/group/noego_traders/

[wrangler]

Thanks for the invitation but I already belong to one group 3SOF and that's the only group I care to join. I'm not knocking you're group but I have very limited time to trade stock and communicate on 3SOF and don't want to take time away from either since it's limited.
Goodluck trading to all